CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 322 enrolled
Drug / intervention
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05201495
NCT05201495N/ACompleted
CompareCT.gov

A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest

Element Science, Inc.·interventional·Posted Jan 21, 2022·Updated Apr 27, 2026

In Brief

A clinical study evaluating Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) for Sudden Cardiac Arrest. Completed, enrolled 322 participants across 30 sites.

Detailed Summary

The Jewel IDE Study: A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest. ("JEWEL")

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSudden Cardiac Arrest
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 21, 2022
Enrollment StartJan 12, 2022
Primary CompletionNov 10, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.4 years ago

Interventions

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)device

Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.